Cite
HARVARD Citation
Poveda, A. et al. (2021). Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21). Obstetrical & gynecological survey. 76 (9), p. . [Online].